ABEO
ABEO
NASDAQ · Biotechnology

Abeona Therapeutics Inc

$5.40
-0.03 (-0.55%)
As of Sep 27, 10:39 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +160.9% upside
Low Target $7.81
Average Target $14.09
High Target $15.42
Current Price $5.40
Current
$5.40
Target
$14.09
$7.81 $14.09 avg $15.42
Scenario Analysis
Bear Case
$7.81
44.6%
Low target
Base Case
$14.09
+160.9%
Avg target
Bull Case
$15.42
+185.6%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$7.65
-29.4% from high
52-Week Low
$4.00
+35.0% from low
Target vs 52W High
$14.09
+84.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%